These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 7649075)
1. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Breeman WA; Lamberts SW Endocrinology; 1995 Sep; 136(9):3698-706. PubMed ID: 7649075 [TBL] [Abstract][Full Text] [Related]
2. Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgery. Hofland LJ; Breeman WA; Krenning EP; de Jong M; Waaijers M; van Koetsveld PM; Mäcke HR; Lamberts SW Proc Assoc Am Physicians; 1999; 111(1):63-9. PubMed ID: 9893158 [TBL] [Abstract][Full Text] [Related]
3. Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in rats. Breeman WA; de Jong M; Bernard B; Hofland LJ; Srinivasan A; van der Pluijm M; Bakker WH; Visser TJ; Krenning EP Anticancer Res; 1998; 18(1A):83-9. PubMed ID: 9568060 [TBL] [Abstract][Full Text] [Related]
4. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells. Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505 [TBL] [Abstract][Full Text] [Related]
6. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090). Faglia G; Bazzoni N; Spada A; Arosio M; Ambrosi B; Spinelli F; Sara R; Bonino C; Lunghi F J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785 [TBL] [Abstract][Full Text] [Related]
8. The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas. Colao A; Lastoria S; Ferone D; Varrella P; Marzullo P; Pivonello R; Cerbone G; Acampa W; Salvatore M; Lombardi G J Endocrinol Invest; 1999 Mar; 22(3):176-83. PubMed ID: 10219884 [TBL] [Abstract][Full Text] [Related]
9. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells. Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274 [TBL] [Abstract][Full Text] [Related]
10. Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. de Jong M; Breeman WA; Bakker WH; Kooij PP; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt MA; Erion JL; Bugaj JE; Mäcke HR; Krenning EP Cancer Res; 1998 Feb; 58(3):437-41. PubMed ID: 9458086 [TBL] [Abstract][Full Text] [Related]
11. Long-term in-vitro treatment of human growth hormone (GH)-secreting pituitary adenoma cells with octreotide causes accumulation of intracellular GH and GH mRNA levels. Hofland LJ; Velkeniers B; vd Lely AJ; van Koetsveld PM; Kazemzadeh M; Waaijers M; Hooghe-Peters EL; Lamberts SW Clin Endocrinol (Oxf); 1992 Sep; 37(3):240-8. PubMed ID: 1424206 [TBL] [Abstract][Full Text] [Related]
12. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915 [TBL] [Abstract][Full Text] [Related]
13. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors. Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735 [TBL] [Abstract][Full Text] [Related]
14. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues. De Jong M; Breeman WA; Bernard HF; Kooij PP; Slooter GD; Van Eijck CH; Kwekkeboom DJ; Valkema R; Mäcke HR; Krenning EP Q J Nucl Med; 1999 Dec; 43(4):356-66. PubMed ID: 10731786 [TBL] [Abstract][Full Text] [Related]
15. Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas. Deng J; Shi Y; Yin J Chin Med J (Engl); 1997 Sep; 110(9):678-81. PubMed ID: 9642323 [TBL] [Abstract][Full Text] [Related]
16. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Viguerie N; Tahiri-Jouti N; Ayral AM; Cambillau C; Scemama JL; Bastié MJ; Knuhtsen S; Estève JP; Pradayrol L; Susini C Endocrinology; 1989 Feb; 124(2):1017-25. PubMed ID: 2563240 [TBL] [Abstract][Full Text] [Related]
17. Structure and function of somatostatin receptors in growth hormone control. Shimon I; Melmed S J Endocrinol; 1997 Oct; 155 Suppl 1():S3-6; discussion S7-8. PubMed ID: 9389989 [TBL] [Abstract][Full Text] [Related]
18. Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy. De Jong M; Bakker WH; Breeman WA; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt M; Béhé M; Mäcke HR; Krenning EP Int J Cancer; 1998 Jan; 75(3):406-11. PubMed ID: 9455802 [TBL] [Abstract][Full Text] [Related]
19. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Bakker WH; Albert R; Bruns C; Breeman WA; Hofland LJ; Marbach P; Pless J; Pralet D; Stolz B; Koper JW Life Sci; 1991; 49(22):1583-91. PubMed ID: 1658515 [TBL] [Abstract][Full Text] [Related]
20. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. Reubi JC; Landolt AM J Clin Endocrinol Metab; 1989 Apr; 68(4):844-50. PubMed ID: 2537844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]